Kodiak Sciences (KOD) Other Non-Current Assets (2016 - 2026)
Kodiak Sciences (KOD) reported Other Non-Current Assets of $8.7 million for Q1 2026, up 40.31% on a YoY basis from $6.2 million in Q1 2025, and little changed quarter-over-quarter from $8.7 million in Q4 2025.
Kodiak Sciences (KOD) Other Non-Current Assets (2016 - 2026) Analysis & Trends
Kodiak Sciences has reported Other Non-Current Assets for 11 years, with the latest figure at $8.7 million in Q1 2026.
- For the quarter ending Q1 2026, Other Non-Current Assets rose 40.31% year-over-year to $8.7 million; the trailing twelve-month figure through Mar 2026 stood at $8.7 million (up 40.31% YoY), and the FY2025 full-year result was $8.7 million, down 0.68% from the prior year.
- Other Non-Current Assets for Q1 2026 stood at $8.7 million, roughly flat from $8.7 million in the prior quarter.
- The five-year high for Other Non-Current Assets was $8.7 million in Q4 2024, with the low at $6.2 million in Q1 2024.
- Historically, Other Non-Current Assets has averaged $6.7 million across 5 years, with a median of $6.3 million in 2022.
- Annual changes were most pronounced in 2024 — Other Non-Current Assets decreased 2.21% — and 2026, when it jumped 40.31%.
- Kodiak Sciences' Other Non-Current Assets stood at $6.3 million in 2022, then changed by 0.0% to $6.3 million in 2023, then soared by 38.01% to $8.7 million in 2024, then fell by 0.68% to $8.7 million in 2025, then rose by 0.09% to $8.7 million in 2026.
- The last three Other Non-Current Assets figures came in at $8.7 million (Q1 2026), $8.7 million (Q4 2025), and $6.2 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | 289.41 Mn |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 12.40 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | 60,000.00 |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 1.26 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | Kodiak Sciences | 1.95 Bn | 1.95 Bn | - | 8.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.68 Mn |
| Dec 31, 2025 | 8.67 Mn |
| Sep 30, 2025 | 6.18 Mn |
| Jun 30, 2025 | 6.18 Mn |
| Mar 31, 2025 | 6.18 Mn |
| Dec 31, 2024 | 8.73 Mn |
| Sep 30, 2024 | 6.18 Mn |
| Jun 30, 2024 | 6.18 Mn |
| Mar 31, 2024 | 6.18 Mn |
| Dec 31, 2023 | 6.32 Mn |
| Sep 30, 2023 | 6.32 Mn |
| Jun 30, 2023 | 6.32 Mn |
| Mar 31, 2023 | 6.32 Mn |
| Dec 31, 2022 | 6.32 Mn |
| Sep 30, 2022 | 6.32 Mn |
| Jun 30, 2022 | 6.32 Mn |
| Mar 31, 2022 | 6.32 Mn |
| Dec 31, 2021 | 6.32 Mn |
| Sep 30, 2021 | 6.32 Mn |
| Jun 30, 2021 | 6.32 Mn |